Roivant Sciences, the umbrella company for Vivek Ramaswamy’s series of ‘vant companies, acquired Silicon Therapeutics for $450 million in Roivant equity.
Much of the conversation at CES 2021 had to do with the emergence of “digital leaders” and “digital laggards” and what an organization finding itself behind the digital transformation curve can do to pull forward.
Global health innovation leader W2O announced the acquisitions of tech-enabled companies Swoop and IPM.ai, further accelerating what is expected to be the company’s 20th consecutive year of double-digit revenue growth.
Data-driven marketing products and services communications firm Relevate Health Group announced the completion of a strategic combination with Arteric, a digital marketing agency known for its proprietary machine learning (ML) driven multichannel digital marketing.
Immunai, a company comprehensively mapping the immune system, announced a collaboration with leading life science technology company 10x Genomics.
Leadership teams from the 2020 Manny Award winners and finalists participated in a Q&A forum to offer their analysis on a variety of healthcare industry themes and trends.
EVERSANA, a pioneer of next-generation commercial services to the global life sciences industry, partnered with WorldQuant Predictive (WQP), a market leader in quantitative predictions and data-driven decisions through a cloud-based artificial intelligence (AI) platform, to improve the end result for patients.
Researchers with Pfizer and IBM developed an artificial intelligence (AI) model that they claim can predict the eventual onset of Alzheimer’s disease with 71% accuracy based on a language sample.
The U.S. National Institutes of Health (NIH) awarded seven companies and academic institutions grants to develop digital health technology to help with the Covid-19 pandemic.
EVERSANA launched ACTICS by EVERSANA, a technology-enabled solution to optimize end-to-end commercial success for life science companies.